Healthcare & Medical Devices Global On demand · 24-48h

Global Stereotactic Radiation Therapy (SRT) System Market Strategic Research Report

Global Stereotactic Radiation Therapy (SRT) System Market St…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Stereotactic Radiation Therapy (SRT) System Market
$3502025
24.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: X-rays, Gamma-rays

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, OUR United Gorp, Jiangsu Rayer Medical Technology, Hygeia Healthcare Holdings

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 94 pages
Market size 2025
$350
Million USD
Forecast CAGR
24.1%
2025-2032
Forecast 2032
$1586.6
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Stereotactic Radiation Therapy (SRT) System market size is predicted to grow from US$ 350 million in 2025 to US$ 1,541 million in 2032; it is expected to grow at a CAGR of 24.1% from 2026 to 2032.

Improvements in tumor localization, imaging and dosimetry in radiotherapy has allowed for the implementation of hypofractionated radiotherapy for disease sites where conventional fractionation (around 2 Gy per fraction) was previously the norm or where curative radiotherapy was not attempted. SRT comprises high-precision irradiation techniques that use multiple, photon radiation beams to deliver a high dose of radiation. Stereotactic localization, using frame-based or frameless techniques, is used to treat lesions. Regarding dose fractionation, SRT is divided into stereotactic radiosurgery (SRS), in which the total dose is delivered in a single treatment session, and stereotactic radiotherapy, in which the total dose is delivered in multiple fractions (usually less than 8 treatments). Originally this technique was only used when treating lesions located in the brain, however now a number of extra-cranial malignancies are treated using stereotactic localization (stereotactic body radiotherapy (SBRT)).

Global key Stereotactic Radiation Therapy (SRT) System players cover Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Stereotactic Radiation Therapy (SRT) System market?

What factors are driving Stereotactic Radiation Therapy (SRT) System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Stereotactic Radiation Therapy (SRT) System market opportunities vary by end market size?

How does Stereotactic Radiation Therapy (SRT) System break out by Type, by Application?

This report presents a comprehensive overview of the global Stereotactic Radiation Therapy (SRT) System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • X-rays
  • Gamma-rays

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Stereotactic Radiation Therapy (SRT) System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Stereotactic Radiation Therapy (SRT) System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 24.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$350
2025
Forecast
$1586.6
2032
CAGR
24.1%
2025–2032
区域
5
global
Key companies
ElektaAccuray IncorporatedMASEP Medical Science & Technology Development (Shenzhen)China Isotope & Radiation CorporationHuiheng GroupOUR United GorpJiangsu Rayer Medical TechnologyHygeia Healthcare Holdings
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
X-raysGamma-rays
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 X-rays
  • 3.1.3 Gamma-rays
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Elekta
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Accuray Incorporated
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 MASEP Medical Science & Technology Development (Shenzhen)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 China Isotope & Radiation Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Huiheng Group
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 OUR United Gorp
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Jiangsu Rayer Medical Technology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Hygeia Healthcare Holdings
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Stereotactic Radiation Therapy (SRT) System market size?
The global Stereotactic Radiation Therapy (SRT) System market is estimated at US$ 350 million in 2025 (base year) and is projected to reach US$ 1.54 billion by 2032.
What growth rate is expected for the Stereotactic Radiation Therapy (SRT) System market through 2032?
The market is expected to grow at a CAGR of 24.1% from 2026 to 2032, expanding from US$ 350 million in 2025 to US$ 1.54 billion in 2032, roughly 4.4 times its base-year value.
How is Stereotactic Radiation Therapy (SRT) System defined?
Improvements in tumor localization, imaging and dosimetry in radiotherapy has allowed for the implementation of hypofractionated radiotherapy for disease sites where conventional fractionation (around 2 Gy per fraction) was previously the norm or where curative radiotherapy was not attempted. SRT comprises high-precision irradiation techniques that use multiple, photon radiation beams to deliver a high dose of radiation. Stereotactic localization, using frame-based or frameless techniques, is used to treat lesions.
How is the Stereotactic Radiation Therapy (SRT) System market segmented by type?
By type, the market is segmented into X-rays and Gamma-rays.
What are the key applications of Stereotactic Radiation Therapy (SRT) System?
Key applications covered include Hospital, Clinic and Other.
Which companies are profiled in the Stereotactic Radiation Therapy (SRT) System market report?
Key players profiled include Elekta, Accuray Incorporated, MASEP Medical Science & Technology Development (Shenzhen), China Isotope & Radiation Corporation, Huiheng Group, OUR United Gorp, Jiangsu Rayer Medical Technology and Hygeia Healthcare Holdings.
What geographies does the Stereotactic Radiation Therapy (SRT) System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Stereotactic Radiation Therapy (SRT) System?
What factors are driving Stereotactic Radiation Therapy (SRT) System market growth, globally and by region?
Who should buy the Stereotactic Radiation Therapy (SRT) System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Stereotactic Radiation Therapy (SRT) System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.